Delivery Order SPE2DX22D0010-SPE2D826FCV88
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $25,466.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 2, 2026, with an ultimate completion date of January 5, 2026. This unset-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,181.92 to AmerisourceBergen Drug Corp on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The contract is executed at the contractor's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,947.12 delivery order to AmerisourceBergen Drug Corp on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation, and the place of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $82,863 to AmerisourceBergen Drug Corp on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., and was competitively awarded with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $107,769.52 to AmerisourceBergen Drug Corp on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order represents a discrete task order issued against this comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $178,629.90 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, has an ultimate completion date of January 20, 2026. The contract was competitively awarded with no set-aside designation, leveraging AmerisourceBergen's established...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $738,830.10 to AmerisourceBergen Drug Corp on September 6, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price delivery order, which is not set-aside, leverages AmerisourceBergen's position as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $118,456.17 to AmerisourceBergen Drug Corp on January 5, 2026, with completion expected by January 6, 2026. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCV88Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,294.57 to AmerisourceBergen Drug Corp on January 31, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office operates as a major pharmaceutical distributor and healthcare solutions provider. This delivery order represents one of numerous task orders executed under the overarching DLA pharmaceutical supply vehicle, which enables AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. The competitively awarded contract reflects AmerisourceBergen's established capability to meet federal procurement requirements for critical medical commodities serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 1/30/26 |